Drug profile · INN
tafamidis meglumine
VYNDAQEL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tafamidis meglumine (VYNDAQEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tafamidis meglumine
Brand VYNDAQEL
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is tafamidis meglumine?
tafamidis meglumine (VYNDAQEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tafamidis meglumine?
VYNDAQEL is a marketed brand name for tafamidis meglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tafamidis meglumine?
tafamidis meglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.